62 related articles for article (PubMed ID: 23581022)
1. Development and use of non-FDG PET radiopharmaceuticals at the Masaryk Memorial Cancer Institute.
Adam J; Bolcak K; Kaderavek J; Kuzel F
Klin Onkol; 2012; 25 Suppl 2():2S82-6. PubMed ID: 23581022
[TBL] [Abstract][Full Text] [Related]
2. [New radiopharmaceuticals and positron-emission tomography applications at the Masaryk Memorial Cancer Institute in Brno].
Adam J; Andres P; Bolcák K; Cermáková M; Demlová R; Dubská L; Sedlácková S; Valík D
Klin Onkol; 2009; 22(3):94-7. PubMed ID: 19708542
[TBL] [Abstract][Full Text] [Related]
3. Clinical PET in oncology: not only FDG.
Nanni C; Rubello D; Al-Nahhas A; Fanti S
Nucl Med Commun; 2006 Sep; 27(9):685-8. PubMed ID: 16894321
[No Abstract] [Full Text] [Related]
4. [Current Progresses in Developing PET Radiopharmaceuticals for Patients in the Czech Republic].
Adam J; Demlová R; Řehák Z
Klin Onkol; 2016; 29 Suppl 4():S95-100. PubMed ID: 27846727
[TBL] [Abstract][Full Text] [Related]
5. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
6. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
7. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Watanabe H; Kanematsu M; Kondo H; Kako N; Yamamoto N; Yamada T; Goshima S; Hoshi H; Bae KT
J Magn Reson Imaging; 2010 May; 31(5):1151-6. PubMed ID: 20432351
[TBL] [Abstract][Full Text] [Related]
8. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892
[TBL] [Abstract][Full Text] [Related]
9. A simple Tracerlab module modification for automated on-column [11C]methylation and [11C]carboxylation.
Lodi F; Trespidi S; Di Pierro D; Marengo M; Farsad M; Fanti S; Franchi R; Boschi S
Appl Radiat Isot; 2007 Jun; 65(6):691-5. PubMed ID: 17158055
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of 18F-FDG-PET and 11C-MET-PET in patients with plasma cell malignancy].
Kobayashi M; Yamashita K; Takaori-Kondo A
Nihon Rinsho; 2015 Jan; 73(1):74-9. PubMed ID: 25626308
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of oncological [11C]radiopharmaceuticals for clinical PET.
Lodi F; Malizia C; Castellucci P; Cicoria G; Fanti S; Boschi S
Nucl Med Biol; 2012 May; 39(4):447-60. PubMed ID: 22172394
[TBL] [Abstract][Full Text] [Related]
12. PET Center - Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Bolcák K
Nucl Med Rev Cent East Eur; 2005; 8(2):160-2. PubMed ID: 16437408
[No Abstract] [Full Text] [Related]
13. [L-[methyl-(11C)]-methionine of high enantiomeric purity production via on-line 11C-methylation of L-homocysteine thiolactone hydrochloride].
Gomzina NA; Kuznetsova OF
Bioorg Khim; 2011; 37(2):216-22. PubMed ID: 21721254
[TBL] [Abstract][Full Text] [Related]
14. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine.
Cook GJ; Maisey MN; Fogelman I
Eur J Nucl Med; 1999 Oct; 26(10):1363-78. PubMed ID: 10541839
[TBL] [Abstract][Full Text] [Related]
15. Exploring Metabolism In Vivo Using Endogenous
Neumann K; Flavell R; Wilson DM
Semin Nucl Med; 2017 Sep; 47(5):461-473. PubMed ID: 28826521
[TBL] [Abstract][Full Text] [Related]
16. PET Radiopharmaceuticals in Brazil and Belarus: Economic Comparison Using the Case of
Brinkevich S; Pires LP; Portilho FL; Santos-Oliveira R
Curr Radiopharm; 2018; 11(1):69-72. PubMed ID: 29231148
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic imaging with 11C-dihydrotetrabenazine PET: a perspective.
Fagan SP; Fischman AJ
J Nucl Med; 2009 Mar; 50(3):335-7. PubMed ID: 19223411
[No Abstract] [Full Text] [Related]
18. The Role of the Practice of Nuclear Pharmacy in Positron Emission Tomography.
Callahan RJ; Dragotakes SC
Clin Positron Imaging; 1999 Jul; 2(4):211-216. PubMed ID: 14516532
[TBL] [Abstract][Full Text] [Related]
19. [Research and development of radiopharmaceuticals for PET scan].
Nishimura S
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2014 Jan; 70(1):76-8. PubMed ID: 24624497
[No Abstract] [Full Text] [Related]
20. Should we assess repeatability of PET quantitative uptake measurements of each
Laffon E; de Clermont H; Buj S; Marthan R
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1272-1273. PubMed ID: 29666891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
